IDEXX Laboratories, Inc.
IDXX
$652.23
-$0.04-0.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.56% | 3.28% | 5.07% | 5.29% | 6.85% |
| Total Depreciation and Amortization | 13.95% | 15.12% | 13.08% | 10.60% | 6.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 510.04% | 142.51% | 134.01% | -85.87% | -68.99% |
| Change in Net Operating Assets | -3,040.76% | -35.17% | -83.96% | 47.73% | 95.30% |
| Cash from Operations | -6.54% | 5.12% | 2.48% | 10.45% | 29.80% |
| Capital Expenditure | 6.72% | 2.99% | 9.51% | 17.35% | 15.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.40% | 100.40% | -- | -- | -568.87% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -201.97% | -207.50% | -212.76% | -47.84% | -- |
| Cash from Investing | 34.16% | 32.67% | -65.31% | -37.21% | -19.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -104.52% | 70.56% | 81.44% | 54.41% | 72.47% |
| Issuance of Common Stock | -14.77% | -44.11% | -5.40% | -11.68% | 24.06% |
| Repurchase of Common Stock | -167.93% | -359.27% | -934.94% | -436.28% | -76.49% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 58.34% | -525.70% |
| Cash from Financing | -104.27% | -141.90% | -98.66% | -63.53% | 11.28% |
| Foreign Exchange rate Adjustments | 336.48% | -219.25% | -548.35% | 46.20% | -2,780.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -188.18% | -181.61% | -148.53% | -109.92% | 1,354.60% |